Pages that link to "Q24649685"
Jump to navigation
Jump to search
The following pages link to Supramaximal dose of candesartan in proteinuric renal disease (Q24649685):
Displaying 50 items.
- Reducing Cardiorenal Risk Through Combination Therapy With a Direct Renin Inhibitor (Q26851307) (← links)
- Antihypertensive treatment and renal protection: the role of drugs inhibiting the renin-angiotensin-aldosterone system (Q26865691) (← links)
- Therapeutic modalities in diabetic nephropathy: standard and emerging approaches. (Q27007027) (← links)
- Monitoring Kidney Function and Albuminuria in Patients With Diabetes (Q27691297) (← links)
- Comparing angiotensin II receptor blockers on benefits beyond blood pressure (Q30360678) (← links)
- Management of hypertension with fixed dose combinations of candesartan cilexetil and hydrochlorothiazide: patient perspectives and clinical utility (Q33571219) (← links)
- World kidney day 2011: protect your kidneys, save your heart (Q33871733) (← links)
- Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications (Q34390088) (← links)
- Cardio classics revisited--focus on the role of candesartan. (Q34417462) (← links)
- Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease (Q34604473) (← links)
- Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T). (Q34627724) (← links)
- Nuclear expression of renin-angiotensin system components in NRK-52E renal epithelial cells (Q34772555) (← links)
- World Kidney Day 2011 - Protect your kidneys, save your heart (Q35673984) (← links)
- The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease (Q35914820) (← links)
- Retarding the progression of chronic kidney disease with renin angiotensin system blockade (Q36082302) (← links)
- The renal protective effect of angiotensin receptor blockers depends on intra-individual response variation in multiple risk markers (Q36125465) (← links)
- Sexual dimorphism in urinary angiotensinogen excretion during chronic angiotensin II-salt hypertension. (Q36166426) (← links)
- Inhibition of renin activity slows down the progression of HIV-associated nephropathy (Q36309378) (← links)
- Renin-Angiotensin-Aldosterone System Blockade in Diabetic Nephropathy. Present Evidences (Q36329456) (← links)
- Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders (Q36410269) (← links)
- Dual Blockade of the Renin-angiotensin-aldosterone System in Type 2 Diabetic Kidney Disease (Q36701736) (← links)
- Candesartan: widening indications for this angiotensin II receptor blocker? (Q37534746) (← links)
- Dual blockade of the renin-angiotensin-aldosterone system: beyond the ACE inhibitor and angiotensin-II receptor blocker combination (Q37574913) (← links)
- Outcomes of antiproteinuric RAAS blockade: high-dose compared with dual therapy (Q37593679) (← links)
- Losartan chemistry and its effects via AT1 mechanisms in the kidney (Q37595616) (← links)
- When to initiate ACEI/ARB therapy in patients with type 1 and 2 diabetes (Q37721287) (← links)
- The RAAS in the pathogenesis and treatment of diabetic nephropathy (Q37741783) (← links)
- Application of direct renin inhibition to chronic kidney disease (Q37758534) (← links)
- Chronic Kidney Disease and Albuminuria in Arterial Hypertension (Q37778763) (← links)
- Which antihypertensive drugs are the most nephroprotective and why? (Q37803235) (← links)
- Combination inhibition of the renin–angiotensin system: is more better? (Q37883908) (← links)
- Managing kidney disease with blood-pressure control (Q37892340) (← links)
- Therapeutic Approaches in Lowering Albuminuria: Travels Along the Renin-Angiotensin-Aldosterone-System Pathway (Q37904097) (← links)
- Renin-angiotensin system blockade and reduction of cardiovascular risk: future perspectives (Q37959062) (← links)
- Improving the efficacy of RAAS blockade in patients with chronic kidney disease (Q38068099) (← links)
- Treatment strategies to prevent renal damage in hypertensive children (Q38187597) (← links)
- Efficacy and safety of supramaximal titrated inhibition of renin-angiotensin-aldosterone system in idiopathic dilated cardiomyopathy (Q38399141) (← links)
- Renin-angiotensin-aldosterone system blockade in chronic kidney disease: current strategies and a look ahead (Q38777543) (← links)
- New Agents in Treatment of Hyperkalemia: an Opportunity to Optimize Use of RAAS Inhibitors for Blood Pressure Control and Organ Protection in Patients with Chronic Kidney Disease (Q38845433) (← links)
- Evaluation of subacute change in RAAS activity (as indicated by urinary aldosterone:creatinine, after pharmacologic provocation) and the response to ACE inhibition (Q39893116) (← links)
- Differential renal effects of candesartan at high and ultra-high doses in diabetic mice-potential role of the ACE2/AT2R/Mas axis (Q41652967) (← links)
- The appropriate dose of angiotensin-converting-enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better? (Q42383448) (← links)
- Progenitor cell secretory products exert additive renoprotective effects when combined with ace inhibitors in experimental CKD. (Q42499130) (← links)
- Regression of glomerulosclerosis in response to transient treatment with angiotensin II blockers is attenuated by blockade of matrix metalloproteinase-2. (Q43106556) (← links)
- Proteinuria: Increased angiotensin-receptor blocking is not the first option. (Q45952180) (← links)
- Achieving remission of proteinuria in childhood CKD. (Q48320229) (← links)
- Pooled Analysis of Multiple Crossover Trials To Optimize Individual Therapy Response to Renin-Angiotensin-Aldosterone System Intervention. (Q50095858) (← links)
- Individual long-term albuminuria exposure during angiotensin receptor blocker therapy is the optimal predictor for renal outcome (Q50730577) (← links)
- Chronic kidney disease prevention--a challenge for Asian countries: report of the Third Asian Forum of Chronic Kidney Disease Initiatives (Q51409315) (← links)
- [Rheumatoid arthritis: subclinical atherosclerosis of the coronary arteries--effect of age, sex and disease activity]. (Q53316049) (← links)